This strategic acquisition substantially expands InnoSer’s preclinical neurology portfolio, adding i...
The TRANSCEND project aims to tackle the current limitations of drug development for Parkinson’s Dis...
As the InnoSer team, we are delighted to share the news – as of this week, we have a renewed vision ...
Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative...
Innoser is putting oncology development at the forefront of our efforts this year. By attending this...
Press release | Diepenbeek, 01 April 2021
One of the greatest challenges in drug development is ensuring that the safety and efficacy results ...
Press release | Leiden, 25 January 2021
InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offe...